Pharmacology and vitreoretinal surgery
著者
書誌事項
Pharmacology and vitreoretinal surgery
(Developments in ophthalmology, v. 44)
Karger, 2009
大学図書館所蔵 全2件
  青森
  岩手
  宮城
  秋田
  山形
  福島
  茨城
  栃木
  群馬
  埼玉
  千葉
  東京
  神奈川
  新潟
  富山
  石川
  福井
  山梨
  長野
  岐阜
  静岡
  愛知
  三重
  滋賀
  京都
  大阪
  兵庫
  奈良
  和歌山
  鳥取
  島根
  岡山
  広島
  山口
  徳島
  香川
  愛媛
  高知
  福岡
  佐賀
  長崎
  熊本
  大分
  宮崎
  鹿児島
  沖縄
  韓国
  中国
  タイ
  イギリス
  ドイツ
  スイス
  フランス
  ベルギー
  オランダ
  スウェーデン
  ノルウェー
  アメリカ
注記
Includes bibliographical references and indexes
内容説明・目次
内容説明
Since the advent of pars plana vitrectomy, immense technical advances in the treatment of retinal diseases have been made. However, some mechanically based limitations of vitreoretinal surgery may result in incomplete removal of the vitreous, especially at the vitreoretinal interface and at the vitreous base. Here, pharmacology can be of assistance. For instance, enzymes that cleave the vitreoretinal junction without damaging the retina or which induce liquefaction may be applied. Neuroprotective and antiproliferative agents may hold the promise of preserving neuronal function when the retina is detached or when proliferative vitreoretinopathy or proliferative diabetic retinopathy has developed. Earlier intervention is possible and can save visual function before the retinal cytoarchitecture is destroyed. Consequently, pharmacologic vitreolysis will change the current concepts of treating retinal and macular diseases. This volume is the first comprehensive up-date on pharmacology-assisted vitreoretinal surgery. Researchers in the fields of medical and surgical retina as well as retinal specialists and vitreoretinal surgeons in clinics will benefit from this topical summary.
目次
- Preface: Gandorfer, A.
- Pharmacologic Vitreolysis
- Objective of Pharmacologic Vitreolysis: Gandorfer, A.
- Vitreous as a Substrate for Vitreolysis: Bishop, P.N.
- Hyaluronidase for Pharmacologic Vitreolysis: Kuppermann, B.
- Narayanan R.
- Microplasmin-Assisted Vitrectomy: Gandorfer, A.
- Pharmacologic Vitreodynamics and Molecular Flux: Goldenberg, D.T
- Trese, M.T.
- Proliferative Vitreoretinopathy
- Glial Cell Changes of the Human Retina in Proliferative Vitreoretinopathy: Wickham, L.
- Charteris, D.G.
- Alkylphosphocholines: A New Approach to Inhibit Cell Proliferation in Proliferative Vitreoretinopathy: Eibl, K.H.
- Fisher, S.K.
- Lewis, G.P.
- Diabetic Retinopathy and Diabetic Macular Edema
- Neuroprotection for Diabetic Retinopathy: Imai, H.
- Singh, R:S:J.
- Fort, P.E.
- Gardner, T.W.
- VEGF Inhibitors and Vitrectomy for Diabetic Vitreoretinopathy: Cury, C.E., Jr.
- Rodrigues, E.B.
- Meyer, C.H.
- Farah, M.E.
- Age-Related Macular Degeneration
- Tissue Plasminogen Activator-Assisted Vitrectomy: Surgical Drainage of Submacular Hemorrhage: Kamei, M
- Tano, Y.
- Retinopathy of Prematurity
- Anti-Angiogenic Therapy in the Management of Retinopathy of Prematurity: Drenser, K.A.
- Author Index
- Subject Index.
「Nielsen BookData」 より